Stay updated with breaking news from Platform Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
03.04.2023 - Expect to complete patient enrollment in the randomized Phase 1/2a SIGNAL-AD Alzheimer’s study in April 2023 with topline data anticipated mid-2024 Completed enrollment of 36 patients required for a pre-planned interim analysis of KEYNOTE B84 ...
Team Phagel from UCL London wins first prize at SCI's 2023 Bright SCIdea finalWinning business idea could address 50% figure of burn victims who die from infectionLONDON, March 31, 2023 /PRNewswire/
/PRNewswire/ -- Calcium is an important nutritional need of every human. However, most calcium supplements lead to unwelcome side effects. Mayo Clinic...
/PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of...
Go-to-Market Solution Provides Full Commercial Support for the First, True Entire Active-Day Medication Designed to treat ADHD Indegene Model Geared for Efficient National Commercial Launch in Multibillion-Dollar